Article
Allicin inhibits SARS-CoV-2 replication and abrogates the antiviral host response in the…
medRxiv · 2021 · Kirstin Mösbauer, author Verena Nadin Fritsch, author Lorenz Adrian, author Jörg Bernhardt, author Martin Clemens Horst Gruhlke, author Alan John Slusarenko, author Daniela Niemeyer, author Haike Antelmann, author
Key facts
| Title | Allicin inhibits SARS-CoV-2 replication and abrogates the antiviral host response in the Calu-3 proteome |
|---|---|
| First author | Kirstin Mösbauer, author Verena Nadin Fritsch, author Lorenz Adrian, author Jörg Bernhardt, author Martin Clemens Horst Gruhlke, author Alan John Slusarenko, author Daniela Niemeyer, author Haike Antelmann, author |
| Journal | medRxiv |
| Published | Jun 24, 2021 |
| DOI | 10.1101/2021.05.15.444275 |
| Devices mentioned | 021464, 200160, K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185 and 3 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 1 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1